Latest / The BioHub - by Avetix
Episode 202 - Ben Swanson - CEO of Skeletalis
Today we're joined by Ben Swanson, Founder and CEO of Skeletalis, a biotechnology company developing a new generation of precision medicines for bone disease.
Ben's path into biotech is anything but conventional. Trained as both a dentist and a scientist, he founded Skeletalis to tackle one of the biggest unmet challenges in musculoskeletal health: how to deliver treatments directly to the parts of the skeleton that need them most, while minimizing effects on the rest of the body.
At Skeletalis, Ben and his team have developed the OASIS platform—a targeted drug delivery approach designed to…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.